Search Results

You are looking at 1 - 10 of 83 items for :

Clear All
Orvosi Hetilap
Authors: Balázs Odler and Veronika Müller

., Vollmer, W. M., et al.: International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet, 2007, 370 (9589), 741–750. 5

Open access
Orvosi Hetilap
Authors: Károly Vincze, Khaled Almuhtadi, Kornél Kelemen, Gyula Horváth and László Tóth

pulmonary disease. In: Murin S., Silvestri G. (eds.): Clinics in Chest Medicine, 2000, 21 , 87–94. Vadász I.: COPD – újabb ismeretek, bővülő lehetőségek. Orvostovábbképző Szemle, 2006, 13 , 13

Restricted access
European Journal of Microbiology and Immunology
Authors: H. Frickmann, S. Jungblut, T. O. Hirche, U. Groß, M. Kuhns and Andreas Erich Zautner

2006 COPD exacerbations 2: aetiology Thorax 61 3 250 – 258 . 3. J.C. Hogg

Restricted access

the first dose in patients with COPD: the GLOW3 trial . Int. J. Chron. Obstruct. Pulmon. Dis. 7 , 503 – 513 ( 2012 ) 4. Beeh KM , Wagner F , Khindri S , Drollmann AF : Effect of indacaterol on dynamic lung hyperinflation and

Restricted access

, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR, COPD Clinical Research Network: Azithromycin for prevention of exacerbations of COPD. N. Engl. J. Med. 365, 689–698 (2011) Anthonisen NR

Restricted access

Speizer F. The Natural History of Chronic Bronchitis and Emphysema 1976 Global Strategy for the Diagnosis, Management and Prevention of COPD. The Global Initiative for Obstructive Lung

Restricted access
Orvosi Hetilap
Authors: Miklós Szabó, Renáta Kun, László Hajba, Roland Koncz, András Guttman and Eszter Csánky

–943. 2 Böszörményi NGy. COPD. [COPD.] Korányi Bull. 2019; 1: 24–31. [Hungarian] 3 Braido F, Bagnasco D, Scichilone N, et al. Biomarkers in obstructive respiratory

Open access
Orvosi Hetilap
Authors: Mónika Fekete, Judit Pákó, Gergő Szőllősi, Krisztina Tóth, Mónika Szabó, Dorottya Horváth and János Tamás Varga

–58. [Hungarian] 2 Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019

Open access
European Journal of Microbiology and Immunology
Authors: Katja Fischer, Jan-Moritz Doehn, Christian Herr, Carolin Lachner, Annina Heinrich, Olivia Kershaw, Meike Voss, Max H. Jacobson, Achim D. Gruber, Matthias Clauss, Martin Witzenrath, Robert Bals, Birgitt Gutbier and Hortense Slevogt

Introduction Chronic obstructive pulmonary disease (COPD) is characterized by chronic bronchitis associated with chronic inflammation of the small airways and in the lung parenchyma, as well as obstruction of the small airways [ 1 ]. Cigarette

Open access

Celli, B., Decramer, M., Leimer, I. és mtsai: Cardiovascular safety of tiotropium in patients with COPD. Chest, 2010, 137 , 20–30. Leimer I

Open access